Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18718647rdf:typepubmed:Citationlld:pubmed
pubmed-article:18718647lifeskim:mentionsumls-concept:C0007138lld:lifeskim
pubmed-article:18718647lifeskim:mentionsumls-concept:C0023501lld:lifeskim
pubmed-article:18718647lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:18718647lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:18718647lifeskim:mentionsumls-concept:C1441055lld:lifeskim
pubmed-article:18718647pubmed:issue4lld:pubmed
pubmed-article:18718647pubmed:dateCreated2009-4-6lld:pubmed
pubmed-article:18718647pubmed:abstractTextA case of a 78-year-old man with transitional cell carcinoma and a paraneoplastic leukemoid reaction. The leukocytosis was present at the diagnosis of carcinoma. It dissipated with complete tumor resection, was absent when a surveillance computed tomography scan showed no evidence of recurrence at 6 months, and had returned with tumor recurrence at 8 months. This case demonstrates that a paraneoplastic leukemoid reaction can be used as a tumor marker in cases of transitional cell carcinoma when a leukemoid reaction is found at presentation.lld:pubmed
pubmed-article:18718647pubmed:languageenglld:pubmed
pubmed-article:18718647pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18718647pubmed:citationSubsetIMlld:pubmed
pubmed-article:18718647pubmed:statusMEDLINElld:pubmed
pubmed-article:18718647pubmed:monthAprlld:pubmed
pubmed-article:18718647pubmed:issn1527-9995lld:pubmed
pubmed-article:18718647pubmed:authorpubmed-author:TierneyLawren...lld:pubmed
pubmed-article:18718647pubmed:authorpubmed-author:DukesJonathan...lld:pubmed
pubmed-article:18718647pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18718647pubmed:volume73lld:pubmed
pubmed-article:18718647pubmed:ownerNLMlld:pubmed
pubmed-article:18718647pubmed:authorsCompleteYlld:pubmed
pubmed-article:18718647pubmed:pagination928.e17-9lld:pubmed
pubmed-article:18718647pubmed:meshHeadingpubmed-meshheading:18718647...lld:pubmed
pubmed-article:18718647pubmed:meshHeadingpubmed-meshheading:18718647...lld:pubmed
pubmed-article:18718647pubmed:meshHeadingpubmed-meshheading:18718647...lld:pubmed
pubmed-article:18718647pubmed:meshHeadingpubmed-meshheading:18718647...lld:pubmed
pubmed-article:18718647pubmed:meshHeadingpubmed-meshheading:18718647...lld:pubmed
pubmed-article:18718647pubmed:meshHeadingpubmed-meshheading:18718647...lld:pubmed
pubmed-article:18718647pubmed:meshHeadingpubmed-meshheading:18718647...lld:pubmed
pubmed-article:18718647pubmed:meshHeadingpubmed-meshheading:18718647...lld:pubmed
pubmed-article:18718647pubmed:year2009lld:pubmed
pubmed-article:18718647pubmed:articleTitleParaneoplastic leukemoid reaction as marker for transitional cell carcinoma recurrence.lld:pubmed
pubmed-article:18718647pubmed:affiliationDepartment of Medicine, University of California, San Francisco, California, USA. jonathan.dukes@jhmi.edulld:pubmed
pubmed-article:18718647pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18718647pubmed:publicationTypeCase Reportslld:pubmed